港股创新药今年涨了100%，背后的逻辑是什么？

Group 1 - The core viewpoint of the article highlights that the Hong Kong stock market's innovative drug sector has surged over 100 points this year, indicating significant growth and investment opportunities in this field [1] Group 2 - Innovative drugs are defined as new pharmaceutical products that offer advanced treatment options, which may have been misunderstood by many investors prior to this surge [1] - The article suggests that the recent surge in innovative drug stocks can be attributed to various factors, including market recovery after a three-year downturn, increased investor interest, and advancements in drug development [1] Group 3 - The article outlines strategies for investing in innovative drugs, emphasizing the importance of understanding the complexities of the sector and the associated risks [1]